Product
Z-1018
1 clinical trial
3 indications
Indication
Herpes zosterIndication
Herpes ZosterIndication
Vaccine-Preventable DiseasesClinical trial
A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 YearsStatus: Completed, Estimated PCD: 2022-10-20